 | • レポートコード： • 出版社/出版日： / • レポート形態：、、ページ数はお問い合わせください。 • 納品方法： |
| ￥ 日本円の価格はお問い合わせください。 (0) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
Market Overview
The global Choroidal Neovascularization market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Choroidal Neovascularization market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Choroidal Neovascularization market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Choroidal Neovascularization market has been segmented into
Intravenous
Intravitreal
By Application, Choroidal Neovascularization has been segmented into:
Extreme Myopia
Malignant Myopic Degeneration
Age-Related Developments
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Choroidal Neovascularization market presented in the report. This section sheds light on the sales growth of different regional and country-level Choroidal Neovascularization markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Choroidal Neovascularization market.
The report offers in-depth assessment of the growth and other aspects of the Choroidal Neovascularization market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Choroidal Neovascularization Market Share Analysis
Choroidal Neovascularization competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Choroidal Neovascularization sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Choroidal Neovascularization sales, revenue and market share for each player covered in this report.
The major players covered in Choroidal Neovascularization are:
Pfizer Inc.
Promedior Inc.
Regeneron Pharmaceuticals Inc.
F. Hoffmann-La Roche Ltd.
Sanwa Kagaku Kenkyusho Co. Ltd.
Novartis AG
Gilead Sciences Inc
QLT Inc.
Bayer AG
Bausch Health
Among other players domestic and global, Choroidal Neovascularization market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Choroidal Neovascularization product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Choroidal Neovascularization, with price, sales, revenue and global market share of Choroidal Neovascularization in 2018 and 2019.
Chapter 3, the Choroidal Neovascularization competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Choroidal Neovascularization breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Choroidal Neovascularization market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Choroidal Neovascularization sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Choroidal Neovascularization Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Choroidal Neovascularization Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Intravenous
1.2.3 Intravitreal
1.3 Market Analysis by Application
1.3.1 Overview: Global Choroidal Neovascularization Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Extreme Myopia
1.3.3 Malignant Myopic Degeneration
1.3.4 Age-Related Developments
1.4 Overview of Global Choroidal Neovascularization Market
1.4.1 Global Choroidal Neovascularization Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Pfizer Inc.
2.1.1 Pfizer Inc. Details
2.1.2 Pfizer Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Pfizer Inc. SWOT Analysis
2.1.4 Pfizer Inc. Product and Services
2.1.5 Pfizer Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Promedior Inc.
2.2.1 Promedior Inc. Details
2.2.2 Promedior Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Promedior Inc. SWOT Analysis
2.2.4 Promedior Inc. Product and Services
2.2.5 Promedior Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Regeneron Pharmaceuticals Inc.
2.3.1 Regeneron Pharmaceuticals Inc. Details
2.3.2 Regeneron Pharmaceuticals Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Regeneron Pharmaceuticals Inc. SWOT Analysis
2.3.4 Regeneron Pharmaceuticals Inc. Product and Services
2.3.5 Regeneron Pharmaceuticals Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche Ltd.
2.4.1 F. Hoffmann-La Roche Ltd. Details
2.4.2 F. Hoffmann-La Roche Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche Ltd. SWOT Analysis
2.4.4 F. Hoffmann-La Roche Ltd. Product and Services
2.4.5 F. Hoffmann-La Roche Ltd. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sanwa Kagaku Kenkyusho Co. Ltd.
2.5.1 Sanwa Kagaku Kenkyusho Co. Ltd. Details
2.5.2 Sanwa Kagaku Kenkyusho Co. Ltd. Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sanwa Kagaku Kenkyusho Co. Ltd. SWOT Analysis
2.5.4 Sanwa Kagaku Kenkyusho Co. Ltd. Product and Services
2.5.5 Sanwa Kagaku Kenkyusho Co. Ltd. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis AG
2.6.1 Novartis AG Details
2.6.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis AG SWOT Analysis
2.6.4 Novartis AG Product and Services
2.6.5 Novartis AG Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Gilead Sciences Inc
2.7.1 Gilead Sciences Inc Details
2.7.2 Gilead Sciences Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Gilead Sciences Inc SWOT Analysis
2.7.4 Gilead Sciences Inc Product and Services
2.7.5 Gilead Sciences Inc Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 QLT Inc.
2.8.1 QLT Inc. Details
2.8.2 QLT Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 QLT Inc. SWOT Analysis
2.8.4 QLT Inc. Product and Services
2.8.5 QLT Inc. Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Bayer AG
2.9.1 Bayer AG Details
2.9.2 Bayer AG Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Bayer AG SWOT Analysis
2.9.4 Bayer AG Product and Services
2.9.5 Bayer AG Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Bausch Health
2.10.1 Bausch Health Details
2.10.2 Bausch Health Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Bausch Health SWOT Analysis
2.10.4 Bausch Health Product and Services
2.10.5 Bausch Health Choroidal Neovascularization Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Choroidal Neovascularization Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Choroidal Neovascularization Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Choroidal Neovascularization Manufacturer Market Share in 2019
3.3.2 Top 6 Choroidal Neovascularization Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Choroidal Neovascularization Sales, Revenue and Market Share by Regions
4.1.1 Global Choroidal Neovascularization Sales and Market Share by Regions (2015-2020)
4.1.2 Global Choroidal Neovascularization Revenue and Market Share by Regions (2015-2020)
4.2 North America Choroidal Neovascularization Sales and Growth Rate (2015-2020)
4.3 Europe Choroidal Neovascularization Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Choroidal Neovascularization Sales and Growth Rate (2015-2020)
4.5 South America Choroidal Neovascularization Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Choroidal Neovascularization Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Choroidal Neovascularization Sales, Revenue and Market Share by Country
5.1.1 North America Choroidal Neovascularization Sales and Market Share by Country (2015-2020)
5.1.2 North America Choroidal Neovascularization Revenue and Market Share by Country (2015-2020)
5.2 United States Choroidal Neovascularization Sales and Growth Rate (2015-2020)
5.3 Canada Choroidal Neovascularization Sales and Growth Rate (2015-2020)
5.4 Mexico Choroidal Neovascularization Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Choroidal Neovascularization Sales, Revenue and Market Share by Country
6.1.1 Europe Choroidal Neovascularization Sales and Market Share by Country (2015-2020)
6.1.2 Europe Choroidal Neovascularization Revenue and Market Share by Country (2015-2020)
6.2 Germany Choroidal Neovascularization Sales and Growth Rate (2015-2020)
6.3 UK Choroidal Neovascularization Sales and Growth Rate (2015-2020)
6.4 France Choroidal Neovascularization Sales and Growth Rate (2015-2020)
6.5 Russia Choroidal Neovascularization Sales and Growth Rate (2015-2020)
6.6 Italy Choroidal Neovascularization Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Choroidal Neovascularization Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Choroidal Neovascularization Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Choroidal Neovascularization Revenue and Market Share by Regions (2015-2020)
7.2 China Choroidal Neovascularization Sales and Growth Rate (2015-2020)
7.3 Japan Choroidal Neovascularization Sales and Growth Rate (2015-2020)
7.4 Korea Choroidal Neovascularization Sales and Growth Rate (2015-2020)
7.5 India Choroidal Neovascularization Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Choroidal Neovascularization Sales and Growth Rate (2015-2020)
7.7 Australia Choroidal Neovascularization Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Choroidal Neovascularization Sales, Revenue and Market Share by Country
8.1.1 South America Choroidal Neovascularization Sales and Market Share by Country (2015-2020)
8.1.2 South America Choroidal Neovascularization Revenue and Market Share by Country (2015-2020)
8.2 Brazil Choroidal Neovascularization Sales and Growth Rate (2015-2020)
8.3 Argentina Choroidal Neovascularization Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Choroidal Neovascularization Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Choroidal Neovascularization Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Choroidal Neovascularization Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Choroidal Neovascularization Sales and Growth Rate (2015-2020)
9.3 Turkey Choroidal Neovascularization Sales and Growth Rate (2015-2020)
9.4 Egypt Choroidal Neovascularization Sales and Growth Rate (2015-2020)
9.5 South Africa Choroidal Neovascularization Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Choroidal Neovascularization Sales and Market Share by Type (2015-2020)
10.2 Global Choroidal Neovascularization Revenue and Market Share by Type (2015-2020)
10.3 Global Choroidal Neovascularization Price by Type (2015-2020)
11 Global Choroidal Neovascularization Market Segment by Application
11.1 Global Choroidal Neovascularization Sales Market Share by Application (2015-2020)
11.2 Global Choroidal Neovascularization Revenue Market Share by Application (2015-2020)
11.3 Global Choroidal Neovascularization Price by Application (2015-2020)
12 Market Forecast
12.1 Global Choroidal Neovascularization Sales, Revenue and Growth Rate (2021-2025)
12.2 Choroidal Neovascularization Market Forecast by Regions (2021-2025)
12.2.1 North America Choroidal Neovascularization Market Forecast (2021-2025)
12.2.2 Europe Choroidal Neovascularization Market Forecast (2021-2025)
12.2.3 Asia-Pacific Choroidal Neovascularization Market Forecast (2021-2025)
12.2.4 South America Choroidal Neovascularization Market Forecast (2021-2025)
12.2.5 Middle East & Africa Choroidal Neovascularization Market Forecast (2021-2025)
12.3 Choroidal Neovascularization Market Forecast by Type (2021-2025)
12.3.1 Global Choroidal Neovascularization Sales Forecast by Type (2021-2025)
12.3.2 Global Choroidal Neovascularization Market Share Forecast by Type (2021-2025)
12.4 Choroidal Neovascularization Market Forecast by Application (2021-2025)
12.4.1 Global Choroidal Neovascularization Sales Forecast by Application (2021-2025)
12.4.2 Global Choroidal Neovascularization Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
加齢黄斑変性薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Age Related Macular Degeneration Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…- 近眼及び老眼治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Myopia and Presbyopia Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 近視コントロールレンズ（子供＆ティーンエイジャー）の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Myopia Control Lenses (Children & Teenagers) market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, va…
- 近視スイミングゴーグルの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Myopia Swimming Goggles market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Myopia Swimming Goggl…
- 近視管理レンズの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The Myopia Management Lenses market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…